Skip to main content
Top
Published in: Clinical Rheumatology 2/2007

01-02-2007 | Original Article

Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus

Authors: H. C. Chong, S. S. Chee, E. M. L. Goh, S. K. Chow, S. S. Yeap

Published in: Clinical Rheumatology | Issue 2/2007

Login to get access

Abstract

The primary objective of this study was to determine the relationship between dietary calcium intake and bone mineral density (BMD) in premenopausal women with systemic lupus erythematosus (SLE) on corticosteroids (CS). The secondary aim was to identify other risk factors for osteoporosis in these patients. A cross-sectional sample of patients attending the SLE Clinic at a teaching hospital was recruited. BMD was measured using dual-energy X-ray absorptiometry. Daily dietary calcium intake was assessed using a structured validated food frequency questionnaire, in which patients were asked to estimate their food intake based on their recent 2-month dietary habits. Sixty subjects were recruited with a mean age of 33.70±8.46 years. The median duration of CS use was 5.5 years (range 0.08–24). The median cumulative dose of steroids was 17.21 g (range 0.16–91.37). The median daily dietary calcium intake was 483 mg (range 78–2101). There was no significant correlation between calcium intake and BMD, even after correcting for CS use. There were also no correlations between BMD and the duration of SLE, cumulative CS use, duration of CS use, smoking, alcohol intake, and SLE disease activity index score. Twenty-eight (46.7%) patients had normal BMD, 28 (46.7%) had osteopenia, and four (6.6%) had osteoporosis. Duration of SLE significantly correlated with cumulative CS dosage. In conclusion, 6.7% of these Asian premenopausal SLE women had osteoporosis and only 46.7% had normal BMD. Daily dietary calcium intake did not correlate with BMD.
Literature
1.
go back to reference Ramsey-Goldman R, Dunn JE, Huang CF et al (1999) Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 42:882–890CrossRefPubMed Ramsey-Goldman R, Dunn JE, Huang CF et al (1999) Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data. Arthritis Rheum 42:882–890CrossRefPubMed
2.
go back to reference Dhillon VB, Davies MC, Hall ML et al (1990) Assessment of effect of oral steroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 49:624–626PubMed Dhillon VB, Davies MC, Hall ML et al (1990) Assessment of effect of oral steroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X-ray absorptiometry. Ann Rheum Dis 49:624–626PubMed
3.
go back to reference Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726–1734PubMed Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36:1726–1734PubMed
4.
go back to reference Pons F, Peris P, Guanabens N et al (1995) The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. Br J Rheumatol 34:742–746PubMed Pons F, Peris P, Guanabens N et al (1995) The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. Br J Rheumatol 34:742–746PubMed
5.
go back to reference Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D (1995) Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 54:274–276PubMedCrossRef Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D (1995) Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 54:274–276PubMedCrossRef
6.
go back to reference Houssiau FA, Lefèbvre C, Depresseux G, Lambert M, Devogelaer J-P, Nagant de Deuxchaisnes C (1996) Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 35:244–247PubMed Houssiau FA, Lefèbvre C, Depresseux G, Lambert M, Devogelaer J-P, Nagant de Deuxchaisnes C (1996) Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 35:244–247PubMed
7.
go back to reference Sinigaglia L, Varenna M, Binelli L et al (1999) Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol 26:1280–1284PubMed Sinigaglia L, Varenna M, Binelli L et al (1999) Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol 26:1280–1284PubMed
8.
go back to reference Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC (1998) Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 37:405–410CrossRefPubMed Li EK, Tam LS, Young RP, Ko GTC, Li M, Lau EMC (1998) Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 37:405–410CrossRefPubMed
9.
go back to reference Jardinet D, Lefèbvre C, Depresseux G, Lambert M, Devogelaer J-P, Houssiau FA (2000) Longitudinal analysis of bone mineral density in pre-menopausal female SLE patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology 39:389–392CrossRefPubMed Jardinet D, Lefèbvre C, Depresseux G, Lambert M, Devogelaer J-P, Houssiau FA (2000) Longitudinal analysis of bone mineral density in pre-menopausal female SLE patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology 39:389–392CrossRefPubMed
10.
go back to reference Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S (2003) Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 30:2365–2368PubMed Uaratanawong S, Deesomchoke U, Lertmaharit S, Uaratanawong S (2003) Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 30:2365–2368PubMed
11.
go back to reference Welten DC, Kemper HCG, Post GB, Van Staveren WA (1995) A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 125:2802–2813PubMed Welten DC, Kemper HCG, Post GB, Van Staveren WA (1995) A meta-analysis of the effect of calcium intake on bone mass in young and middle aged females and males. J Nutr 125:2802–2813PubMed
12.
go back to reference Matkovic V, Fontana D, Tominac C et al (1990) Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr 52:878–888PubMed Matkovic V, Fontana D, Tominac C et al (1990) Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr 52:878–888PubMed
13.
go back to reference French SA, Fulkerson JA, Story M (2000) Increasing weight-bearing physical activity and calcium intake for bone mass growth in children and adolescents: a review of intervention trials. Prev Med 31:722–731CrossRefPubMed French SA, Fulkerson JA, Story M (2000) Increasing weight-bearing physical activity and calcium intake for bone mass growth in children and adolescents: a review of intervention trials. Prev Med 31:722–731CrossRefPubMed
14.
go back to reference Merrilees MJ, Smart EJ, Gilchrist NL et al (2000) Effects of dairy food supplements on bone mineral density in teenage girls. Eur J Nutr 39:256–262CrossRefPubMed Merrilees MJ, Smart EJ, Gilchrist NL et al (2000) Effects of dairy food supplements on bone mineral density in teenage girls. Eur J Nutr 39:256–262CrossRefPubMed
15.
go back to reference Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1275PubMed Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1275PubMed
16.
go back to reference Chee SS, Suriah AR, Zaitun Y et al (2002) Dietary calcium intake in postmenopausal Malaysian women: a comparison between the food frequency questionnaire and three day records. Asia Pacific J Clin Nutr 11:142–146CrossRef Chee SS, Suriah AR, Zaitun Y et al (2002) Dietary calcium intake in postmenopausal Malaysian women: a comparison between the food frequency questionnaire and three day records. Asia Pacific J Clin Nutr 11:142–146CrossRef
17.
go back to reference Tee ES, Ismail MN, Nasir MA, Idris K (1997) Nutrient composition of Malaysian food, 4th edn. Institute for Medical Research, Kuala Lumpur Tee ES, Ismail MN, Nasir MA, Idris K (1997) Nutrient composition of Malaysian food, 4th edn. Institute for Medical Research, Kuala Lumpur
18.
go back to reference Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640PubMed
19.
go back to reference World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843. WHO, Geneva World Health Organization (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series, No. 843. WHO, Geneva
20.
go back to reference Chee SS, Ismail MN, Ng KK, Zawiah H (1997) Food intake assessment of adults in rural and urban areas from four selected regions in Malaysia. Malays J Nutr 3:91–102 Chee SS, Ismail MN, Ng KK, Zawiah H (1997) Food intake assessment of adults in rural and urban areas from four selected regions in Malaysia. Malays J Nutr 3:91–102
21.
go back to reference NIH Consensus Development Panel on Optimal Calcium Intake (1994) Optimal calcium intake. JAMA 272:1942–1947CrossRef NIH Consensus Development Panel on Optimal Calcium Intake (1994) Optimal calcium intake. JAMA 272:1942–1947CrossRef
22.
go back to reference Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929PubMed Kipen Y, Buchbinder R, Forbes A, Strauss B, Littlejohn G, Morand E (1997) Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of steroids. J Rheumatol 24:1922–1929PubMed
23.
go back to reference Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777–787CrossRefPubMed
24.
go back to reference Heinonen A, Kannus P, Sievanen H et al (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347CrossRefPubMed Heinonen A, Kannus P, Sievanen H et al (1996) Randomised controlled trial of effect of high-impact exercise on selected risk factors for osteoporotic fractures. Lancet 348:1343–1347CrossRefPubMed
25.
go back to reference Wallace BA, Cumming RG (2000) Systemic review of randomised trials on the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 67:10–18CrossRefPubMed Wallace BA, Cumming RG (2000) Systemic review of randomised trials on the effect of exercise on bone mass in pre- and postmenopausal women. Calcif Tissue Int 67:10–18CrossRefPubMed
26.
go back to reference Eastell R, Reid DM, Compston J et al (1998) A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 224:271–292CrossRef Eastell R, Reid DM, Compston J et al (1998) A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update. J Intern Med 224:271–292CrossRef
27.
go back to reference American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496–1503CrossRef American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496–1503CrossRef
Metadata
Title
Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus
Authors
H. C. Chong
S. S. Chee
E. M. L. Goh
S. K. Chow
S. S. Yeap
Publication date
01-02-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-006-0258-6

Other articles of this Issue 2/2007

Clinical Rheumatology 2/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.